Cambridge, Massachusetts, United States
> Designing and delivering evidence for therapies to treat rare neurological diseases.
> Promoted to lead company’s first major strategic and operational initiative. > Developed long-term vision and key performance metrics in partnership with CEO. > Delivered plan to 3x revenue by identifying over 30 opportunities, developing integrated business cases, and leading collaborative process to select new services. > Guided team to define company mission, values, and expectations for each role, resulting in positive changes that were recognized as transformational by staff and external consultants. > Created product plan, budget, and go-to-market strategy for two new offerings.
> Senior member of leadership team, focused on cultivating client relationships, project and people management, finding opportunities to improve and grow current business, and ensuring operational and methodological excellence. > Led end-to-end project management with the world’s largest pharmaceutical companies, including Pfizer, Sanofi, Boehringer Ingelheim, Roche, Otsuka, LEO, Medtronic and more.
> Technical expert consulting with pharmaceutical companies o design and deliver original research to support new drugs and devices. > Specialized in earning new business by generating solutions to most challenging problems: creating original analytical frameworks, connecting dots unseen by others, rapidly synthesizing complex information. > Created time and cost savings by championing adoption of new research software.
> Academic partner appointed to generate data-driven insights and inform budget decisions at Health Quality Ontario, a government agency working to improve value across the health system. > Helped identify $250 million in savings by designing real world evidence analyses. > Advised decision-makers on the uptake and removal of medical services and devices in Ontario. > Contributed key insights for payment negotiations between government and doctors. > Presented methodological contributions at several international conferences. > Co-tutored an MSc course in healthcare decision analysis with Dr. Murray Krahn.
> Senior Health Economist at the NICE National Clinical Guideline Centre. > Represented NICE at external stakeholder consultations and guideline development meetings.
> Core technical team member on two NICE Clinical Guidelines. > Collaborated with cross-functional teams to define research priorities and develop evidence to support over 60 recommendations that directly impact patients in the UK National Health Service.
> Study coordinator and research analyst at the Canadian Osteoarthritis Research Program. > Collected data from patients and surgeons across three Toronto sites for a multi-national trial. > Conducted qualitative analyses of patient interviews which contributed to new theory of OA pain.